Labcorp Holdings Inc. (LH) Insider Trading

Last 12 months

Insiders sold $13.7M and bought nothing on the open market.

60% of the selling was scheduled in advance under 10b5-1 plans. President & CEO Adam H Schechter sold $2.44M on Mar 3, 9.7% of their stake, outside a plan. The last open-market buy by an executive or director was in Sep 2022.

Net open-market

−$13.7M

0 buys · 20 sales

Under a 10b5-1 plan

60%

of the value sold

Insiders who bought / sold

0 / 10

executives and directors

Last open-market buy

Sep 2022

Sep 7, 2022

Get an email when LH's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Aug 17	Kerrii B Anderson Director	Sold10b5-1 plan	3,000	$318.02	$954k	30%	Form 4
Aug 11	Adam H Schechter President & CEO	Sold10b5-1 plan	4,669	$320.37	$1.5M	4.4%	Form 4
Aug 4	Amy B. Summy EVP, Chief Marketing Officer	SoldNo plan	924	$306.74	$283k	12%	Form 4
Aug 3	Peter J Wilkinson SVP, Chief Accounting Officer	SoldNo plan 2 parts	1,420	$309.23 average	$439k	45%	Form 4
Jul 2	Kathryn W Kyle EVP, Chief Legal Officer	Sold10b5-1 plan	92	$286.19	$26k	2.3%	Form 4
Jul 2	Bryan T Vaughn EVP and President, Diagnostics	Sold10b5-1 plan	234	$286.19	$67k	3.4%	Form 4
Jun 8	Kathryn W Kyle EVP, Chief Legal Officer	Sold10b5-1 plan	762	$263.89	$201k	17%	Form 4
May 11	Adam H Schechter President & CEO	Sold10b5-1 plan	5,903	$254.50	$1.5M	5.2%	Form 4
Mar 27	Peter J Wilkinson SVP, Chief Accounting Officer	Sold10b5-1 plan	1,633	$267.05	$436k	47%	Form 4
Mar 27	Jonathan C Meltzer EVP, Operations	Sold10b5-1 plan	839	$267.05	$224k	19%	Form 4
Mar 3	Adam H Schechter President & CEO	SoldNo plan	8,705	$279.96	$2.44M	9.7%	Form 4
Feb 27	Sandra D Van Der Vaart EVP, Corporate Affairs	SoldNo plan	548	$284.91	$156k	18%	Form 4
Feb 24	Brian J Caveney EVP, Pres of ED, CMO & CSO	SoldNo plan	1,500	$286.31	$429k	4.7%	Form 4
Feb 19	Peter J Wilkinson SVP, Chief Accounting Officer	Sold10b5-1 plan	666	$277.94	$185k	26%	Form 4
Feb 12	Jonathan C Meltzer EVP, Operations	Sold10b5-1 plan	87	$290.42	$25k	3.0%	Form 4
Feb 11	Adam H Schechter President & CEO	Sold10b5-1 plan	5,273	$284.38	$1.5M	5.6%	Form 4
Feb 10	Jonathan C Meltzer EVP, Operations	Sold10b5-1 plan	91	$276.79	$25k	3.3%	Form 4
Feb 9	Jonathan C Meltzer EVP, Operations	Sold10b5-1 plan	88	$275.53	$24k	3.1%	Form 4
Nov 11, 2025	Adam H Schechter President & CEO	Sold10b5-1 plan	5,745	$262.75	$1.51M	6.2%	Form 4
Oct 31, 2025	Richelle P Parham Director	SoldNo plan	7,009	$254.28	$1.78M	74%	Form 4
Aug 13, 2025	Sandra D Van Der Vaart EVP, Chief Legal Officer	SoldNo plan	3,903	$271.42	$1.06M	63%	Form 4
Aug 11, 2025	Adam H Schechter President & CEO	Sold10b5-1 plan	5,643	$266.78	$1.51M	5.7%	Form 4
Jul 30, 2025	Dwight Gary Gilliland Director	SoldNo plan	2,000	$264.95	$530k	23%	Form 4
Jul 29, 2025	Peter J Wilkinson SVP, Chief Accounting Officer	SoldNo plan 2 parts	202	$261.02 average	$53k	9.8%	Form 4
Jul 24, 2025	Kerrii B Anderson Director	Sold10b5-1 plan	3,500	$280.00	$980k	29%	Form 4
Jul 24, 2025	Kerrii B Anderson Director	Sold10b5-1 plan	3,500	$280.00	$980k	29%	Form 4
Jul 1, 2025	Kerrii B Anderson Director	Sold10b5-1 plan	500	$265.00	$133k	3.9%	Form 4
Jun 11, 2025	Kerrii B Anderson Director	Sold10b5-1 plan	500	$260.00	$130k	3.7%	Form 4
Jun 3, 2025	Brian J Caveney EVP, Pres of ED, CMO & CSO	SoldNo plan	2,000	$247.00	$494k	6.2%	Form 4
May 12, 2025	Adam H Schechter President & CEO	Sold10b5-1 plan	6,105	$248.73	$1.52M	5.8%	Form 4
May 1, 2025	Sandra D Van Der Vaart EVP, Chief Legal Officer	SoldNo plan	1,900	$238.36	$453k	46%	Form 4
May 1, 2025	Peter J Wilkinson SVP, Chief Accounting Officer	SoldNo plan	829	$242.27	$201k	29%	Form 4
Mar 28, 2025	Amy B. Summy EVP, Chief Marketing Officer	Sold10b5-1 plan	758	$231.67	$176k	13%	Form 4
Mar 28, 2025	Mark S Schroeder EVP, Pres Diagnostics & COO	Sold10b5-1 plan	2,635	$231.67	$610k	35%	Form 4
Mar 5, 2025	Kerrii B Anderson Director	SoldNo plan	500	$255.63	$128k	3.6%	Form 4
Feb 28, 2025	Mark S Schroeder EVP, Pres Diagnostics & COO	Sold10b5-1 plan	5,339	$249.23	$1.33M	52%	Form 4
Feb 25, 2025	Sandra D Van Der Vaart EVP, Chief Legal Officer	SoldNo plan	1,314	$251.30	$330k	38%	Form 4
Feb 24, 2025	Amy B. Summy EVP, Chief Marketing Officer	Sold10b5-1 plan	226	$250.40	$57k	4.7%	Form 4
Feb 18, 2025	Peter J Wilkinson SVP, Chief Accounting Officer	SoldNo plan	1,413	$246.10	$348k	41%	Form 4
Feb 11, 2025	Adam H Schechter President & CEO	Sold10b5-1 plan	6,121	$244.62	$1.5M	6.5%	Form 4

Aug 1710b5-1 plan
Kerrii B Anderson
Director · sold 3,000 at $318.02
$954k
30% of stake
Aug 1110b5-1 plan
Adam H Schechter
President & CEO · sold 4,669 at $320.37
$1.5M
4.4% of stake
Aug 4No plan
Amy B. Summy
EVP, Chief Marketing Officer · sold 924 at $306.74
$283k
12% of stake
Aug 3No plan
Peter J Wilkinson
SVP, Chief Accounting Officer · sold 1,420 at avg $309.23
$439k
45% of stake
Jul 210b5-1 plan
Kathryn W Kyle
EVP, Chief Legal Officer · sold 92 at $286.19
$26k
2.3% of stake
Jul 210b5-1 plan
Bryan T Vaughn
EVP and President, Diagnostics · sold 234 at $286.19
$67k
3.4% of stake
Jun 810b5-1 plan
Kathryn W Kyle
EVP, Chief Legal Officer · sold 762 at $263.89
$201k
17% of stake
May 1110b5-1 plan
Adam H Schechter
President & CEO · sold 5,903 at $254.50
$1.5M
5.2% of stake
Mar 2710b5-1 plan
Peter J Wilkinson
SVP, Chief Accounting Officer · sold 1,633 at $267.05
$436k
47% of stake
Mar 2710b5-1 plan
Jonathan C Meltzer
EVP, Operations · sold 839 at $267.05
$224k
19% of stake
Mar 3No plan
Adam H Schechter
President & CEO · sold 8,705 at $279.96
$2.44M
9.7% of stake
Feb 27No plan
Sandra D Van Der Vaart
EVP, Corporate Affairs · sold 548 at $284.91
$156k
18% of stake
Feb 24No plan
Brian J Caveney
EVP, Pres of ED, CMO & CSO · sold 1,500 at $286.31
$429k
4.7% of stake
Feb 1910b5-1 plan
Peter J Wilkinson
SVP, Chief Accounting Officer · sold 666 at $277.94
$185k
26% of stake
Feb 1210b5-1 plan
Jonathan C Meltzer
EVP, Operations · sold 87 at $290.42
$25k
3.0% of stake
Feb 1110b5-1 plan
Adam H Schechter
President & CEO · sold 5,273 at $284.38
$1.5M
5.6% of stake
Feb 1010b5-1 plan
Jonathan C Meltzer
EVP, Operations · sold 91 at $276.79
$25k
3.3% of stake
Feb 910b5-1 plan
Jonathan C Meltzer
EVP, Operations · sold 88 at $275.53
$24k
3.1% of stake
Nov 11, 202510b5-1 plan
Adam H Schechter
President & CEO · sold 5,745 at $262.75
$1.51M
6.2% of stake
Oct 31, 2025No plan
Richelle P Parham
Director · sold 7,009 at $254.28
$1.78M
74% of stake
Aug 13, 2025No plan
Sandra D Van Der Vaart
EVP, Chief Legal Officer · sold 3,903 at $271.42
$1.06M
63% of stake
Aug 11, 202510b5-1 plan
Adam H Schechter
President & CEO · sold 5,643 at $266.78
$1.51M
5.7% of stake
Jul 30, 2025No plan
Dwight Gary Gilliland
Director · sold 2,000 at $264.95
$530k
23% of stake
Jul 29, 2025No plan
Peter J Wilkinson
SVP, Chief Accounting Officer · sold 202 at avg $261.02
$53k
9.8% of stake
Jul 24, 202510b5-1 plan
Kerrii B Anderson
Director · sold 3,500 at $280.00
$980k
29% of stake
Jul 24, 202510b5-1 plan
Kerrii B Anderson
Director · sold 3,500 at $280.00
$980k
29% of stake
Jul 1, 202510b5-1 plan
Kerrii B Anderson
Director · sold 500 at $265.00
$133k
3.9% of stake
Jun 11, 202510b5-1 plan
Kerrii B Anderson
Director · sold 500 at $260.00
$130k
3.7% of stake
Jun 3, 2025No plan
Brian J Caveney
EVP, Pres of ED, CMO & CSO · sold 2,000 at $247.00
$494k
6.2% of stake
May 12, 202510b5-1 plan
Adam H Schechter
President & CEO · sold 6,105 at $248.73
$1.52M
5.8% of stake
May 1, 2025No plan
Sandra D Van Der Vaart
EVP, Chief Legal Officer · sold 1,900 at $238.36
$453k
46% of stake
May 1, 2025No plan
Peter J Wilkinson
SVP, Chief Accounting Officer · sold 829 at $242.27
$201k
29% of stake
Mar 28, 202510b5-1 plan
Amy B. Summy
EVP, Chief Marketing Officer · sold 758 at $231.67
$176k
13% of stake
Mar 28, 202510b5-1 plan
Mark S Schroeder
EVP, Pres Diagnostics & COO · sold 2,635 at $231.67
$610k
35% of stake
Mar 5, 2025No plan
Kerrii B Anderson
Director · sold 500 at $255.63
$128k
3.6% of stake
Feb 28, 202510b5-1 plan
Mark S Schroeder
EVP, Pres Diagnostics & COO · sold 5,339 at $249.23
$1.33M
52% of stake
Feb 25, 2025No plan
Sandra D Van Der Vaart
EVP, Chief Legal Officer · sold 1,314 at $251.30
$330k
38% of stake
Feb 24, 202510b5-1 plan
Amy B. Summy
EVP, Chief Marketing Officer · sold 226 at $250.40
$57k
4.7% of stake
Feb 18, 2025No plan
Peter J Wilkinson
SVP, Chief Accounting Officer · sold 1,413 at $246.10
$348k
41% of stake
Feb 11, 202510b5-1 plan
Adam H Schechter
President & CEO · sold 6,121 at $244.62
$1.5M
6.5% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch LH, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Services-Medical Laboratories

DGXQuest Diagnostics Inc.

EXASExact Sciences Corp

NTRANATERA INC (Common Stock) – ticker 45E

FTREFortrea Holdings Inc.

RDNTRadNet Inc.

BTSGBrightSpring Health Services, Inc.

DVADaVita Inc.

CYHCommunity Health Systems, Inc.

Spot a number that looks wrong? Check it in LH's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing LH

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.